|
|
| (One intermediate revision by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Terazosin#Overdosage]] |
| {{Terazosin}}
| |
| {{CMG}}; {{AE}} {{AK}}
| |
| | |
| ==OVERDOSAGE==
| |
| | |
| Should overdosage of terazosin capsules lead to [[hypotension]], support of the cardiovascular system is of first importance. Restoration of blood pressure and normalization of heart rate may be accomplished by keeping the patient in the supine position. If this measure is inadequate, shock should first be treated with volume expanders. If necessary, [[vasopressors]] should then be used and renal function should be monitored and supported as needed. Laboratory data indicate that terazosin capsules are 90-94% protein bound; therefore, [[dialysis]] may not be of benefit.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = TERAZOSIN HYDROCHLORIDE CAPSULE [CARDINAL HEALTH] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=30503dfd-03bd-46d8-8170-d9ed096fd71d | publisher = | date = | accessdate = 7 March 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |